RA Capital Management, L.P.
All transactions
| Move | Company | Δ shares | Value | Impact |
|---|---|---|---|---|
| Buy | CLYM Climb Bio, Inc. | +7,111 | $24.9K | low |
| Other | CDTX CIDARA THERAPEUTICS, INC. | -4,652,309 | $1.03B | low |
| Other | CDTX CIDARA THERAPEUTICS, INC. | +1,286,786 | $129 | low |
| Buy | SGP SpyGlass Pharma, Inc. | +248,034 | $3.97M | high |
| Buy | SGP SpyGlass Pharma, Inc. | +3,441,966 | $55.07M | high |
| Other | SGP SpyGlass Pharma, Inc. | +1,806,644 | — | low |
| Other | SGP SpyGlass Pharma, Inc. | +2,524,473 | — | low |
| Other | EVMN Evommune, Inc. | +35,868 | $1000.0K | low |
| Buy | ACET Adicet Bio, Inc. | +74,577 | $525.0K | high |
| Buy | ACET Adicet Bio, Inc. | +74,268 | $535.5K | high |
| Other | MLYS MINERALYS THERAPEUTICS INC | +6,200 | $0 | low |
| Buy | ACET Adicet Bio, Inc. | +74,751 | $543.4K | high |
| Buy | BCAX Bicara Therapeutics Inc. | +300,000 | $4.80M | high |
| Other | ABOS Acumen Pharmaceuticals, Inc. | +6,060,606 | $20.00M | low |
| Buy | MLYS MINERALYS THERAPEUTICS INC | +310,700 | $7.35M | high |
| Buy | MLYS MINERALYS THERAPEUTICS INC | +58,300 | $1.41M | high |
| Sell | VOR Vor Biopharma Inc. | -1,525 | $29.1K | low |
| Sell | VOR Vor Biopharma Inc. | -258,475 | $4.71M | medium |
| Sell | VOR Vor Biopharma Inc. | -6,775 | $125.3K | medium |
| Sell | VOR Vor Biopharma Inc. | -44,728 | $774.2K | medium |
| Sell | VOR Vor Biopharma Inc. | -537,754 | $8.88M | medium |
| Sell | VOR Vor Biopharma Inc. | -130,862 | $2.21M | medium |
| Sell | VOR Vor Biopharma Inc. | -353,242 | $5.76M | medium |
| Sell | VOR Vor Biopharma Inc. | -135,201 | $2.24M | medium |
| Sell | VOR Vor Biopharma Inc. | -828 | $13.0K | low |
| Sell | VOR Vor Biopharma Inc. | -530,610 | $8.57M | medium |
| Sell | VOR Vor Biopharma Inc. | -153,735 | $2.46M | medium |
| Sell | VOR Vor Biopharma Inc. | -53,644 | $858.8K | medium |
| Sell | VOR Vor Biopharma Inc. | -458,411 | $7.46M | medium |
| Sell | VOR Vor Biopharma Inc. | -171,963 | $2.71M | medium |
| Sell | VOR Vor Biopharma Inc. | -165,150 | $2.60M | medium |
| Other | ACRV Acrivon Therapeutics, Inc. | +3,888,888 | $7.00M | low |
| Other | ACET Adicet Bio, Inc. | -250,000 | — | low |
| Other | PRLD Prelude Therapeutics Incorporated | -1,407,000 | — | low |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +133,750 | $2.41M | high |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +2,541,250 | $45.74M | high |
| Other | COAG Hemab Therapeutics Holdings, Inc. | +221,188 | — | low |
| Other | COAG Hemab Therapeutics Holdings, Inc. | +1,009,052 | — | low |
| Other | COAG Hemab Therapeutics Holdings, Inc. | +3,607,846 | — | low |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +10,268 | $256.7K | medium |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +87,143 | $2.14M | high |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +53,407 | $1.33M | high |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +14,611 | $347.3K | medium |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +1,985 | $49.5K | low |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +7,921 | $192.8K | medium |
| Sell | HOWL Werewolf Therapeutics, Inc. | -25,012 | $17.8K | low |
| Sell | HOWL Werewolf Therapeutics, Inc. | -351,514 | $249.6K | medium |
| Buy | COAG Hemab Therapeutics Holdings, Inc. | +1,483 | $37.0K | low |
| Buy | ARTV Artiva Biotherapeutics, Inc. | +6,510,416 | $75.00M | high |
| Sell | HOWL Werewolf Therapeutics, Inc. | -5,812 | $3.9K | low |